p53 deacetylation alleviates calcium oxalate deposition-induced renal fibrosis by inhibiting ferroptosis
Authors:
Open Access
- 24 May 2023
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 164, 114925
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81870471)
- National Natural Science Foundation of China (82100806)
- National Natural Science Foundation of China (82170775)
- National Natural Science Foundation of China (82270802)
- Key Research and Development Project of Hainan Province (2020BCB017)
- Science and Technology Program of Hubei Province (2019AEA170)
This publication has 29 references indexed in Scilit:
- P53 in kidney injury and repair: Mechanism and therapeutic potentialsPharmacology & Therapeutics, 2019
- Tumor suppressor p53 and metabolismJournal of Molecular Cell Biology, 2018
- Anti-Transforming Growth Factor β IgG Elicits a Dual Effect on Calcium Oxalate Crystallization and Progressive Nephrocalcinosis-Related Chronic Kidney DiseaseFrontiers in Immunology, 2018
- p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer CellsCell Reports, 2018
- The Sirt1 activator, SRT1720, attenuates renal fibrosis by inhibiting CTGF and oxidative stressInternational Journal of Molecular Medicine, 2017
- Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor SuppressionCell Reports, 2016
- Hyperoxaluria Requires TNF Receptors to Initiate Crystal Adhesion and Kidney Stone DiseaseJournal of the American Society of Nephrology, 2016
- Minimally Invasive Surgical Treatment for Kidney Stone DiseaseAdvances in Chronic Kidney Disease, 2015
- Ferroptosis as a p53-mediated activity during tumour suppressionNature, 2015
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012